Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Prevalence and risk factors for obesity after liver transplantation: a single-center experience.

Akarsu M, Bakir Y, Karademir S, Unek T, Bacakoglu A, Astarcioglu I.

Hepat Mon. 2013 Aug 1;13(8):e7569. doi: 10.5812/hepatmon.7569. eCollection 2013.

2.

Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.

Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.

Transpl Immunol. 2008 Nov;20(1-2):32-42. doi: 10.1016/j.trim.2008.08.005. Epub 2008 Sep 4.

PMID:
18773960
3.

Prevalence and risk factors of renal dysfunction after liver transplant: a single-center experience.

Dehghani SM, Derakhshan A, Taghavi SA, Gholami S, Jalaeian H, Malek-Hosseini SA.

Exp Clin Transplant. 2008 Mar;6(1):25-9.

4.

Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.

Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.

Dig Liver Dis. 2009 May;41(5):350-6. doi: 10.1016/j.dld.2008.09.018. Epub 2008 Nov 28.

PMID:
19046932
5.

Bariatric surgery: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(1):1-148. Epub 2005 Jan 1.

6.

Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.

Stegall MD, Wachs ME, Everson G, Steinberg T, Bilir B, Shrestha R, Karrer F, Kam I.

Transplantation. 1997 Dec 27;64(12):1755-60.

PMID:
9422416
7.

[De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates].

Rambusch EG, Nashan B, Tillmann HL, Böker KH, Schlitt HJ, Maschek H, Raab R, Manns MP.

Z Gastroenterol. 1998 Dec;36(12):1027-35. German.

PMID:
10025054
8.

Weight gain and obesity after liver transplantation.

Richards J, Gunson B, Johnson J, Neuberger J.

Transpl Int. 2005 Apr;18(4):461-6.

9.

Prevalence and risk factors of obesity, hypertension, dyslipidemia and diabetes mellitus before and after adult living donor liver transplantation.

Hara Y, Kawagishi N, Nakanishi W, Tokodai K, Nakanishi C, Miyagi S, Ohuchi N.

Hepatol Res. 2015 Jul;45(7):764-70. doi: 10.1111/hepr.12418. Epub 2014 Oct 9.

PMID:
25196899
10.

Hepatitis viruses and liver transplantation.

Samuel D, Feray C, Bismuth H.

J Gastroenterol Hepatol. 1997 Oct;12(9-10):S335-41. Review.

PMID:
9407355
11.

Development of growth and body mass index after pediatric renal transplantation.

Vester U, Schaefer A, Kranz B, Wingen AM, Nadalin S, Paul A, Malagò M, Broelsch CE, Hoyer PF.

Pediatr Transplant. 2005 Aug;9(4):445-9.

PMID:
16048595
12.

Posttransplantation diabetes mellitus: prevalence and risk factors.

Baltar J, Ortega T, Ortega F, Laures A, Rebollo P, Gomez E, Alvarez-Grande J.

Transplant Proc. 2005 Nov;37(9):3817-8.

PMID:
16386548
13.

Small bowel transplant: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2003;3(1):1-72. Epub 2003 Apr 1.

14.

Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.

Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen HR, Yersiz H, Markmann JF, Drazan KE, Holt C, Imagawa D, Goldstein LI, Martin P, Busuttil RW.

Ann Surg. 1999 Jun;229(6):824-31; discussion 831-3.

15.

Incidence of development of obesity after heart transplantation according to the calcineurin inhibitor.

López-Vilella R, Sánchez-Lázaro IJ, Martínez-Dolz L, Almenar-Bonet L, Marqués-Sulé E, Melero-Ferrer J, Portolés-Sanz M, Rivera-Otero M, Domingo-Valero D, Montero-Argudo A.

Transplant Proc. 2015 Jan-Feb;47(1):127-9. doi: 10.1016/j.transproceed.2014.11.025. Erratum in: Transplant Proc. 2015 Oct;47(8):2556.

PMID:
25645789
16.

Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus.

Jain A, Kashyap R, Marsh W, Rohal S, Khanna A, Fung JJ.

Transplantation. 2001 Apr 27;71(8):1102-6.

PMID:
11374410
17.

Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors.

Ollech JE, Kramer MR, Peled N, Ollech A, Amital A, Medalion B, Saute M, Shitrit D.

Eur J Cardiothorac Surg. 2008 May;33(5):844-8. doi: 10.1016/j.ejcts.2008.01.050. Epub 2008 Mar 12.

PMID:
18339554
18.

High body mass index and posttransplant weight gain are not risk factors for kidney graft and patient outcome.

Marcén R, Fernández A, Pascual J, Teruel JL, Villafruela JJ, Rodriguez N, Martins J, Burgos FJ, Ortuño J.

Transplant Proc. 2007 Sep;39(7):2205-7.

PMID:
17889138
19.

Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine.

Taler SJ, Textor SC, Canzanello VJ, Schwartz L, Porayko M, Wiesner RH, Krom RA.

Transplantation. 1996 Dec 15;62(11):1588-92.

PMID:
8970613
20.

Post-transplant diabetes mellitus: risk factors, frequency of transplant rejections, and long-term prognosis.

Schiel R, Heinrich S, Steiner T, Ott U, Stein G.

Clin Exp Nephrol. 2005 Jun;9(2):164-9.

PMID:
15980953
Items per page

Supplemental Content

Write to the Help Desk